Point72 Asia (Singapore) Pte. Ltd. Amphastar Pharmaceuticals, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 4,502 shares of AMPH stock, worth $178,324. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,502
Previous 447
907.16%
Holding current value
$178,324
Previous $27.7 Million
614.71%
% of portfolio
0.05%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
276Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$241 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$108 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$82.3 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$65.7 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$60 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.94B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...